保健管理センター

Keyphrases

1. IgG4-related Disease (IgG4-RD) 100%
2. At-risk Mental State 54%
3. Schizophrenia 54%
4. Insulin 54%
5. Insulin Receptor 41%
6. Atrial Fibrillation 35%
7. Psychosis 32%
8. Transesophageal Echocardiography 28%
9. Non-small Cell Lung Cancer (NSCLC) 25%
10. Fibroblasts 25%
11. First-episode Psychosis 23%
12. Clinical High Risk for Psychosis (CHR-P) 23%
13. Lung Cancer 22%
14. Phosphorylation 21%
15. Insulin Resistance 21%
16. Non-valvular Atrial Fibrillation 21%
17. Schizophrenic Patients 20%
18. Insulin Signaling 19%
19. IgG4-positive Plasma Cell 18%
20. Cognitive Function 18%
21. Glucose Transporter 4 (GLUT4) 17%
22. Patients with Schizophrenia 17%
23. 3T3-L1 Adipocytes 17%
24. Type 2 Diabetes Mellitus (T2DM) 17%
25. Clinical Features 17%
26. Mitogen-activated Protein Kinase 16%
27. Inositol Phosphatase 16%
28. Healthy Controls 16%
29. Mitogenesis 16%
30. Phosphoinositide 3-kinase (PI3K) 16%
31. Rat1 15%
32. Overexpressing 15%
33. Tyrosine Phosphorylation 14%
34. Diagnostic Criteria 14%
35. Individuals at Risk 14%
36. Variant Angina 13%
37. Insulin Receptor Substrate 1 (IRS1) 12%
38. Japan 12%
39. Older Men 12%
40. Thromboembolic Risk 11%
41. Interleukin-6 11%
42. Progression-free Survival 11%
43. Socio-cognitive 11%
44. Small Cell Lung Cancer 11%
45. Lung Lesions 11%
46. Serum Levels 11%
47. Confidence Interval 11%
48. Immune Checkpoint Inhibitors 11%
49. High Risk 10%
50. Functional Importance 10%
51. Elderly Patients 10%
52. SH3 Domain 10%
53. Japanese Population 10%
54. SHIP2 10%
55. Clinical Course 10%
56. Human Lung Fibroblasts 10%
57. Thromboembolism 10%
58. Immune Checkpoint Inhibitor Therapy 10%
59. Monotherapy 10%
60. Mikulicz's Disease 10%
61. SRT1720 10%
62. Interleukin-8 10%
63. Lung Field 10%
64. Risk Factors 9%
65. Plasma Membrane 9%
66. Lipoproteins 9%
67. Rating Scales 9%
68. Sirtuin 1 (SIRT1) 9%
69. Left Atrial Appendage 9%
70. Tumor Necrosis Factor-α 9%
71. IgG4-related Respiratory Disease 8%
72. Autoimmune Pancreatitis 8%
73. Insulin Stimulation 8%
74. Serum IgG4 8%
75. IgG4-related Kidney Disease 8%
76. IgG4-positive 8%
77. Hemostatic Markers 8%
78. Odds Ratio 8%
79. Pathological Features 8%
80. Ischemic Stroke 8%
81. Lung 8%
82. Fibrosis 8%
83. Grb2 8%
84. Negative Regulation 8%
85. Glycogen Synthesis 8%
86. Sinus Rhythm 8%
87. Patient Characteristics 8%
88. Fever 8%
89. CHADS2 Score 8%
90. Muscle Cells 8%
91. Control Subjects 8%
92. Japanese Patients 7%
93. Coronary Artery Spasm 7%
94. Social Functioning 7%
95. Tumor 7%
96. Functional Role 7%
97. MRI Study 7%
98. Phosphatidylinositol 3 7%
99. Young Patients 7%
100. Airway Epithelial Cells 7%

Medicine and Dentistry

1. Immunoglobulin G4 70%
2. Atrial Fibrillation 43%
3. IgG4-Related Disease 41%
4. Disease 36%
5. Lung 22%
6. Lung Cancer 22%
7. Transesophageal Echocardiography 17%
8. Thromboembolism 16%
9. Silo-Filler's Disease 16%
10. Immunoglobulin Producing Cell 16%
11. Diagnosis 15%
12. Non Small Cell Lung Cancer 15%
13. Lung Lesion 13%
14. Small Cell Lung Cancer 11%
15. Immune Checkpoint Inhibitor 11%
16. Hemostat 11%
17. Glucose Transporter 4 11%
18. Disease Course 10%
19. Sinus Rhythm 10%
20. Epithelial Cell 10%
21. Mikulicz Disease 9%
22. At Risk Mental State 9%
23. Immunoglobulin G4 Related Disease 9%
24. Glucocorticoid 9%
25. Chemotherapy 9%
26. Apoplexy 8%
27. Aortic Atherosclerosis 8%
28. Retrospective Study 8%
29. Idiopathic Interstitial Pneumonia 8%
30. CHADS2 Score 8%
31. Computer Assisted Tomography 7%
32. Bronchiolitis 7%
33. Recurrent Disease 7%
34. Nephropathy 7%
35. Cellular Infiltration 7%
36. Fibrosis 7%
37. Elderly Patient 7%
38. Hypercoagulability 7%
39. Angina pectoris 7%
40. Odds Ratio 6%
41. U Wave 6%
42. Atrial Flutter 6%
43. Peripheral Blood Mononuclear Cell 6%
44. Lung Aspergillosis 6%
45. Insulin Receptor 6%
46. Sirtuin1 6%
47. Cell Membrane 6%
48. Diabetes Mellitus 6%
49. Dyspnea 6%
50. Autoimmune Pancreatitis 6%
51. Cardiovascular System 6%
52. Progression Free Survival 6%
53. Thorax Radiography 6%
54. Clinical Feature 6%
55. Diabetes 5%
56. Coughing 5%
57. Glucose Uptake 5%
58. Bronchiolitis Obliterans Organizing Pneumonia 5%
59. Coronary Vasospasm 5%
60. Brain Ischemia 5%
61. Ground Glass Opacity 5%
62. Respiratory Disease 5%
63. Adverse Event 5%
64. Glomerular Filtration Rate 5%
65. Amino Terminal Sequence 5%
66. Carboxy Terminal Sequence 5%
67. Brain Infarction 5%
68. D-Dimer 5%
69. Lipoprotein 5%
70. Astaxanthin 5%
71. Muscle Cell 5%